Federal contract award

75N98025P01559

PINE PHARMACEUTICALS, LLC:1270808 [25-001246] THE CURRENT TRIAL RELIES ON UNIFORMITY OF DRUG FORMULATION, EXCIPIENT COMPOSITION, APPEARANCE, AND PACKAGING THROUGHOUT THE STUDY PERIOD.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH OLAO
NAICS339112 — Surgical and Medical Instrument Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$122.0K
Current contract value$122.0K
Potential contract value / ceiling$122.0K
Start dateJun 20, 2025
Current end dateJan 31, 2026
Potential end dateJan 31, 2026
Latest award activityJun 18, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 18, 20250$122.0KPINE PHARMACEUTICALS, LLC:1270808 [25-001246] THE CURRENT TRIAL RELIES ON UNIFORMITY OF DRUG FORMULATION, EXCIPIENT COMPOSITION, APPEARANCE, AND PACKAGING THROUGHOUT THE STUDY PERIOD.

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.